An About Face As Biogen Says It Will File Aducanumab In Alzheimer’s

 
• By Mandy Jackson
  
Profile of a human head with a colorful symbol of neurons in the brain
Biogen revived once-discontinued aducanumab and plans to file for US FDA approval. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D